Medpace Holdings, Inc.·4

Mar 1, 4:32 PM ET

EWALD STEPHEN P 4

4 · Medpace Holdings, Inc. · Filed Mar 1, 2024

Insider Transaction Report

Form 4
Period: 2024-02-29
EWALD STEPHEN P
General Counsel & Corp. Secy.
Transactions
  • Sale

    Common Stock

    2024-02-29$393.50/sh1,163$457,64613,691 total
  • Sale

    Common Stock

    2024-03-01$400.79/sh350$140,27713,341 total
Footnotes (2)
  • [F1]Represents shares sold to satisfy tax withholding obligations upon the vesting of restricted stock units previously granted to the Reporting Person.
  • [F2]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $399.7028 to $403.1386. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

Documents

1 file
  • 4
    wk-form4_1709328708.xmlPrimary

    FORM 4